Follow The Filings

SOPH SOPHiA GENETICS

SOPHiA GENETICS earnings company data as of 7:49 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by SOPH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SOPH insider trades
  • $99K bought by 1 insider
  • None no sales outside a trading plan
  • $3.2M sold by 7 insiders under 10b5-1 plans
  1. Philippe Menu Chief Medical Officer
    Planned sale
    $36K 5,000 shares at $7.26 2.5% of stake
    Traded Oct 12 Filed Oct 14
    ↗
  2. Zhenyu Xu Chief Scientific Officer
    Planned sale
    $29K 4,000 shares at $7.18 0.7% of stake
    Traded Oct 13 Filed Oct 14
    ↗
  3. Jurgi Camblong Chair
    Planned sale
    $62K 8,500 shares at $7.26 0.3% of stake
    Traded Oct 12 Filed Oct 14
    ↗
  4. Philippe Menu Chief Medical Officer
    Planned sale
    $39K 5,000 shares at $7.88 2.3% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  5. Zhenyu Xu Chief Scientific Officer
    Planned sale
    $32K 4,000 shares at $7.88 0.7% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  6. Daan Van Well Chief Legal Officer
    Planned sale
    $47K 6,168 shares at $7.63 1.8% of stake
    Traded Sep 11 Filed Sep 14
    ↗
  7. Jurgi Camblong Chair
    Planned sale
    $65K 8,500 shares at $7.66 0.2% of stake
    Traded Sep 10 Filed Sep 14
    ↗
  8. Kathy L Hibbs Director
    Planned sale
    $51K 6,250 shares at $8.13 6.1% of stake
    Traded Sep 8 Filed Sep 10
    ↗
  9. Zhenyu Xu Chief Scientific Officer
    Planned sale
    $89K 10,000 shares at $8.91 1.8% of stake
    Traded Aug 27 Filed Aug 31
    ↗
  10. Philippe Menu Chief Medical Officer
    Planned sale
    $43K 5,000 shares at $8.68 2.3% of stake
    Traded Aug 25 Filed Aug 26
    ↗
  11. Kathy L Hibbs Director
    Planned sale
    $54K 6,250 shares at $8.68 5.7% of stake
    Traded Aug 25 Filed Aug 26
    ↗
  12. Abhimanyu Verma Chief Technology Officer
    Planned sale
    $85K 10,000 shares at $8.50 5.5% of stake
    Traded Aug 19–24 Filed Aug 26
    ↗
  13. Manuela Valente Chief People Officer
    Planned sale
    $79K 10,000 shares at $7.94 4.5% of stake
    Traded Aug 19 Filed Aug 21
    ↗
  14. Zhenyu Xu Chief Scientific Officer
    Planned sale
    $163K 20,000 shares at $8.17 3.4% of stake
    Traded Aug 19–21 Filed Aug 21
    ↗
  15. Philippe Menu Chief Medical Officer
    Planned sale
    $38K 5,000 shares at $7.52 2.2% of stake
    Traded Aug 12 Filed Aug 14
    ↗

Also filed in the last 12 months, not counted as buying or selling: 92 sales to cover taxes, 14 stock grants, and 7 option exercises.

SEC filings

Recent issuer filings from EDGAR, 1 shown.

Filed Form Detail Links
6-K Filing Doc

Source: SEC EDGAR submissions, updated 9 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.